These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12632343)

  • 1. Increased microvascular density predicts relapse in Wilms' tumor.
    Abramson LP; Grundy PE; Rademaker AW; Helenowski I; Cornwell M; Katzenstein HM; Reynolds M; Arensman RM; Crawford SE
    J Pediatr Surg; 2003 Mar; 38(3):325-30; discussion 325-30. PubMed ID: 12632343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
    Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
    J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
    Nicolin G; Taylor R; Baughan C; Shannon R; Stevens S; Richardson D; Kelsey A; Pritchard-Jones K; Mitchell C
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):175-80. PubMed ID: 17980506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
    Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
    Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
    J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
    Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late recurrence in children with Wilms' tumor.
    Büyükpamukçu M; Köksal Y; Varan A; Atahan L; Cağlar M; Akyüz C; Kutluk T; Büyükpamukçu N
    Turk J Pediatr; 2007; 49(2):226-30. PubMed ID: 17907529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour.
    Ozluk Y; Kilicaslan I; Gulluoglu MG; Ayan I; Uysal V
    Pathology; 2006 Oct; 38(5):408-14. PubMed ID: 17008278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Wilms' tumors: a single-center experience with 19 cases.
    Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
    J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
    Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
    J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.